Vedolizumab May Offer Hope for People with Colitis or Crohn’s Disease

One experimental drug that has been developed may be the answer for patients affected by inflammatory bowel disease that have been unresponsive to current medications. The drug is known as vedolizumab and is being developed to treat two forms of IBD – ulcerative colitis and Crohn’s Disease.

Both of these diseases occur in the digestive tract and can lead to chronic inflammation, abdominal cramps, diarrhea, and rectal bleeding. During new trials, researchers have discovered that vedolizumab had succeeded in cases where standard medications have been ineffective.

The drug was reported to be more effective for colitis than for Crohn’s. The drug may receive FDA approval for the treatment of colitis first. This is a potential new solution for the 2,000 patients that have either colitis or Crohn’s and have failed to see improvements from standard medications.

During a single trial, 47 percent of a group of 900 colitis patients given vedolizumab infusions reported a decrease in symptoms.

Our Blogs

Comprehensive Care is Our Top Priority

Back to BlogsAt the Center for Digestive Health, your safety is our top priority. We are committed to providing comprehensive care with a focus on patient well-being and comfort. Our expert team ensures that every step of your journey is handled with precision and...

Signs You’re Having Acid Reflux

Back to BlogsAre you experiencing frequent heartburn, a persistent cough, or difficulty swallowing? These could be signs of acid reflux, a common digestive issue that can lead to more serious health problems if left untreated. It's not just about discomfort—acid...

Understanding Acid Reflux: What You Need to Know

Acid reflux is a condition that affects many people, yet it's often misunderstood. At its core, acid reflux occurs when stomach acid flows back up into the esophagus, the tube that connects your throat to your stomach. This backward flow can cause a burning sensation...